Adjuvant sintilimab-capecitabine versus capecitabine alone in locoregionally advanced nasopharyngeal carcinoma with suboptimal response to induction chemotherapy: An open-label, randomized, controlled, phase 2 trial.
Li-Ting Liu, H. Mai, Qiu-Yan Chen, Ling-Quan Tang, Ting-Ting Quan, Jie Chen, Hui Cheng, Yi-Fu Li, Xue-Song Sun, Lin Wu, Sai-Lan Liu, Shan-Shan Guo, Rui Sun, Xiao-Yun Li, W. Xia, Ling Guo, H. Mo